Your browser doesn't support javascript.
loading
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.
Magagnoli, M; Spina, M; Balzarotti, M; Timofeeva, I; Isa, L; Michieli, M; Capizzuto, R; Morenghi, E; Castagna, L; Tirelli, U; Santoro, A.
Afiliación
  • Magagnoli M; Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano, Milan, Italy. massimo.magagnoli@humanitas.it
Bone Marrow Transplant ; 40(11): 1019-25, 2007 Dec.
Article en En | MEDLINE | ID: mdl-17906705
We explored the efficacy of the IGEV regimen (ifosfamide, gemcitabine, vinorelbine and prednisone) combined with a fixed dose of lenograstim (263 mug/day) to mobilize peripheral blood stem cells (PBSCs) in 90 Hodgkin's lymphoma patients. The median total CD34+ cells/mul peak, colony-forming units granulocyte-macrophage and white blood cells for all individual collection sets were 85/mul, 12 x 10(4)/kg and 20 700/mul, respectively. An adequate number of CD34+ cells (more than 3 x 10(6) or 6 x 10(6) CD34+ cells/kg depending on whether single or tandem high-dose chemotherapy was used) were collected in 89 out of 90 (98.7%) mobilized patients, whereas the only failure reached 2.3 x 10(6) CD34+ cells/kg. The median CD34+ cell collections were 11 x 10(6)/kg (range 2.3-39 x 10(6)/kg) and 10 x 10(6)/kg (range 6-22.0 x 10(6)/kg) with a median of 1 and 2 leukaphereses for patients eligible for single high-dose treatment and for candidates for tandem transplant, respectively. Target yields were reached in 71.43 and 49.09% and additionally in 17.14 and 43.64% of cases after the first and second apheresis procedures, respectively. Hematological and non-hematological side effects were acceptable, and no toxic deaths occurred. Thirty-four patients received a single and 47 received tandem transplantation with rapid engraftment. These results confirm that the IGEV regimen with lenograstim support can be used successfully and safely to mobilize PBSCs.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Factores Estimulantes de Colonias / Terapia Recuperativa / Movilización de Célula Madre Hematopoyética Límite: Adult / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2007 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Factor Estimulante de Colonias de Granulocitos / Factores Estimulantes de Colonias / Terapia Recuperativa / Movilización de Célula Madre Hematopoyética Límite: Adult / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2007 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido